Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs
Metadata
Title
Acknowledgement to Referees
Publication date
01-12-2014
Publisher
Springer International Publishing
Published in
Drugs / Issue 18/2014
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-014-0330-5

Other articles of this Issue 18/2014

Drugs 18/2014 Go to the issue

Adis Drug Evaluation

Rifaximin: A Review of Its Use in Reducing Recurrence of Overt Hepatic Encephalopathy Episodes

R&D Insight Report

Ripasudil: First Global Approval

Adis Drug Evaluation

Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes

Adis Drug Evaluation

Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease

Leading Article

Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis

Therapy in Practice

Combining a GLP-1 Receptor Agonist and Basal Insulin: Study Evidence and Practical Considerations